Skip to content
← Full study record

NCT00627393 · OUTCOME

Percentage of Participants Who Are Alive at 42 Days After Treatment and Have Had Microbial Response

Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) · Source last updated 2015-04-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
Not reported
Time frame
Measured at Day 42

What was measured

Microbial response was defined as follows: * A negative blood culture test at 42 days after randomization for subjects with fungemia (candidemia or fusariosis) or bacteremia. * Improvement of signs and symptoms of infectious disease (complete or partial response) at 42 days after randomization.

Analysis population: All adjudicated or deceased subjects in intention-to-treat analyses.

Groups in this outcome

Control Arm

Received antimicrobial therapy alone.

Granulocyte Arm

Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control Arm49
Granulocyte Arm48

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control Arm42.9Not reportedNot reportedNot reportedNot reported
Granulocyte Arm41.7Not reportedNot reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Lower Limit
    0.44
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    3.20
    estimate Comment
    Control group is the reference group. Model adjusted for infection strata, underlying disease, zubrod score, respiratory symptoms, and age.
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    p Value
    0.73
    param Type
    Odds Ratio (OR)
    param Value
    1.19
    statistical Comment
    Ordinary multiple logistic regression including treatment arm, infection strata, underlying disease, zubrod score, respiratory symptoms, and age.
    statistical Method
    Regression, Logistic
    tested Non Inferiority
    false
Complete source fields
analyses
  1. ci Lower Limit
    0.44
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    3.20
    estimate Comment
    Control group is the reference group. Model adjusted for infection strata, underlying disease, zubrod score, respiratory symptoms, and age.
    group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    p Value
    0.73
    param Type
    Odds Ratio (OR)
    param Value
    1.19
    statistical Comment
    Ordinary multiple logistic regression including treatment arm, infection strata, underlying disease, zubrod score, respiratory symptoms, and age.
    statistical Method
    Regression, Logistic
    tested Non Inferiority
    false
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        42.9
      2. group Id
        OG001
        value
        41.7
denoms
  1. counts
    1. group Id
      OG000
      value
      49
    2. group Id
      OG001
      value
      48
    units
    Participants
description
Microbial response was defined as follows: * A negative blood culture test at 42 days after randomization for subjects with fungemia (candidemia or fusariosis) or bacteremia. * Improvement of signs and symptoms of infectious disease (complete or partial response) at 42 days after randomization.
groups
  1. description
    Received antimicrobial therapy alone.
    id
    OG000
    title
    Control Arm
  2. description
    Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.
    id
    OG001
    title
    Granulocyte Arm
param Type
NUMBER
population Description
All adjudicated or deceased subjects in intention-to-treat analyses.
reporting Status
POSTED
time Frame
Measured at Day 42
title
Percentage of Participants Who Are Alive at 42 Days After Treatment and Have Had Microbial Response
type
PRIMARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice